![]() |
市場調查報告書
大麻檢驗的全球市場:成長,趨勢,預測(2020年∼2025年)Cannabis Testing Market - Growth, Trends, and Forecast (2020 - 2025) |
||||||
出版商 | Mordor Intelligence Pvt Ltd | 商品編碼 | 925329 | ||||
出版日期 | 內容資訊 | 英文 120 Pages 商品交期: 2-3個工作天內 |
|||||
價格 |
|
大麻檢驗的全球市場:成長,趨勢,預測(2020年∼2025年) Cannabis Testing Market - Growth, Trends, and Forecast (2020 - 2025) | ||
出版日期: 2020年02月01日 | 內容資訊: 英文 120 Pages |
|
全球大麻檢驗市場在2020年∼2025年間,預測將以約11.3%的年複合成長率成長。市場成長的主要原因,是對醫療用大麻的使用核準增加。大麻萃取物多用於神經及精神障礙的治療,隨著這些障礙的發生率逐漸增加,大麻的使用和生產增加,因此導致檢驗市場成長。根據世界衛生組織,在2019年中約有4億5,000萬人苦於現在這樣的狀態,精神疾病成為全球疾病和身體障礙的主要原因。憂鬱症是最常見的精神障礙。全球全部年齡中有2億6400萬人以上罹患憂鬱症。受到憂鬱症的影響的女性數比男性大量,再加上大麻的實驗室中LIMS的認知度和採用的高漲,也是推動市場的又1個要素。但,大麻的檢查裝置相關的高成本,是市場成長的阻礙因素。
本報告提供全球大麻檢驗市場的相關調查,市場機會和趨勢,成長及阻礙因素,各市場區隔和各地區的市場分析,競爭情形,主要企業的簡介等資訊。
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
The cannabis testing market studied was projected to grow with a CAGR of nearly 11.3% over the forecast period. The major factor attributing to the growth of the market is the increasing approval for the use of medical cannabis. Cannabis extracts are used to treat many neurological and mental disorders, so as the incidence of these disorders increase, the use and production of cannabis increases, resulting in the growth of the testing market. According to the World Health Organization, as of the year 2019, approximately 450 million people presently suffer from such conditions, placing mental disorders among the leading causes of ill-health and disability globally. Depression is the most common mental disorder. Globally, more than 264 million people of all ages suffer from depression. More number of women are affected by depression than men.Furthermore, growing awareness and adoption of LIMS in labs testing cannabis is another factor boosting the market. However the high cost involved in the cannabis testing instruments is major drawback of the market growth.
Analytical Instruments Segment is Dominating the Cannabis Testing Market.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.
The cannabis testing market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market Agilent Technologies, Inc., Shimadzu Scientific Instruments., Merck KGaA, Restek Corporation, PerkinElmer Inc., Danaher Corporation, Accelerated Technology Laboratories, Inc., Steep Hill Halent Laboratories, Inc., Digipath, Inc., Pharmlabs LLC.